Loading clinical trials...

Exploration of the Deep Transcranial Magnetic Stimulation for Treatment Resistant Schizophrenia | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT05167942

Exploration of the Deep Transcranial Magnetic Stimulation for Treatment Resistant Schizophrenia

Negative symptoms and cognitive dysfunction are of importance for the prognosis of the patients of schizophrenia. Based on the hypothesis that deep transcranial magnetic stimulation(dTMS) on prefronta...

Lead sponsor: Shanghai Mental Health Center•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Dengtang Liu, M.D.

CONTACT

8618017311138 [email protected]

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment87

Start dateNov 2021

Last updatedDec 22, 2021

Condition

Treatment Resistant Schizophrenia Based on the DTMS

Locations shown

Shanghai Mental Health Center

Shanghai

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 22, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions